Susanne Eder
Valneva Austria GmbH
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Anu Kantele, MD PhD
Helsinki University Central Hospital
Shared therapeutic areas:
Sam Nightingale, MRCP
Institute of Infection and Global Health, University of Liverpool, Apex Building, 8 West Derby Street, Liverpool, L69 7BE, UK
Shared therapeutic areas:
Nicole Haas
Valneva Austria GmbH
Shared therapeutic areas:
Worked with same sponsors:
Xing Fang
Liaoning Provincial Center for Disease Control and Prevention
Shared therapeutic areas:
Novartis vaccines and Diagnostics
Novartis Vaccines
Shared therapeutic areas:
Huanyu Wang
Liaoning Chengda Biotechnology CO., LTD
Shared therapeutic areas:
Nigel Hill, PhD
London School of Hygiene and Tropical Medicine
Shared therapeutic areas:
Tom Solomon, MRCP, PhD
Director,Institute of Infection and Global Health, University of Liverpool, Apex Building, 8 West Derby Street, Liverpool, L69 7BE, UK , Head- Liverpool Brain Infection Group
Shared therapeutic areas:
Anand Dubey, M.D
Maulana Azad Medical College, New Delhi, India
Shared therapeutic areas:
Ajit Rayamajhi, MBBS, MD
Institute of Infection and Global Health, University of Liverpool, Liverpool, UK & Kanti Children's Hospital, Maharajgunj, Kathmandu, Nepal
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
All 2 trials loaded